Clinical Trials List
Protocol Number20250089
Not yet recruiting
2025-09-25 - 2027-09-30
Phase II
Recruiting1
ICD-10C96.2
Malignant mast cell tumor
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9202.60
Malignant mast cell tumors, unspecified site, extranodal solid organ sites
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- KUO-HSUAN HSU Division of Thoracic Medicine
- JENG-SEN TSENG Division of Thoracic Medicine
- YEN-HSIANG HUANG Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
1 participants
-
Global
24 participants
